Results 221 to 230 of about 338,947 (383)
Detection of circulating immune complexes in patients with atopic dermatitis and psoriasis
Alexander Kapp+3 more
openalex +2 more sources
Data were included from adolescents with moderate‐to‐severe AD treated with the JAK1 inhibitor abrocitinib (200 mg/100 mg) across JADE clinical trials. Improvements in skin clearance (per EASI‐75) and itch (per PP‐NRS4) were maintained for up to 112 weeks with both abrocitinib doses.
Amy S. Paller+13 more
wiley +1 more source
Development of Objective Measurements of Scratching as a Proxy of Atopic Dermatitis-A Review. [PDF]
Au CY+3 more
europepmc +1 more source
Response to Taïeb's "Evidence-Based Moisturizer Selection for Atopic Dermatitis". [PDF]
Shobnam N+4 more
europepmc +1 more source
Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study [PDF]
TH. JOOST+5 more
openalex +1 more source
Methotrexate in the treatment of atopic dermatitis. [PDF]
Nowicki RJ+4 more
europepmc +1 more source
Magnitude of atopic dermatitis and associated factors among children in northwest Ethiopia. [PDF]
Tegegnie AB+4 more
europepmc +1 more source
247 Hydroxyzine: Pharmacokinetics and antipruritic effect in children with atopic dermatitis
F SIMONS+3 more
openalex +1 more source